Abstract:Tumor necrosis factor superfamily-15 (TNFSF15; VEGI) is an endogenous inhibitor of neovascularization. TNFSF15 is largely produced by quiescent vascular endothelial cells in an established vasculature but is markedly down-regulated in endothelial cells undergoing proliferation such as those in tumors or at a wound site. Recombinant TNFSF15 is a potent inhibitor of endothelial cell proliferation and tumor growth. We hypothesize that TNFSF15 as a negative regulator of angiogenesis must be down-regulated prior to the initiation of angiogenesis, and that the inflammatory conditions created by cancer cells and infiltrating lymphocytes lead to TNFSF15 down-modulation in the microenvironment, permitting new blood vessel growth. We analyzed normal ovary tissues (n=12) and clinical specimens of ovarian cancer (n=86; including stages I, II, III and IV) for the expression of TNFSF15, the endothelial cell marker PECAM (CD31), and tumor-infiltrating T-cell markers CD4 and CD25. We found that the degree of T-cell infiltration increases markedly while TNFSF15 expression diminishes as the disease progresses. We then determined the influence of human ovarian cancer cell line OVCAR-3 cell conditioned media on cytokine production by human CD4+ T-cells and CD4+CD25+ Treg cells, as well as the influence of the conditioned media of the latter two cells on TNFSF15 expression in human umbilical vein endothelial cells (HUVEC). We found that the conditioned media of Th1 or Treg cells can inhibit HUVEC TNFSF15 expression only after the lymphocytes being treated with OVCAR-3 conditioned media. Interestingly, we further found that mouse ovarian cancer ID8 cells implanted subcutaneously on mice treated with TNFSF15 shRNA at the injection sites exhibit significantly greater tumor growth rates compared with control shRNA treated ones. Our findings indicate that TNFSF15 plays a critical role in the maintenance of vascular stability as its down-modulation is a pre-requisite for the initiation of tumor neovascularization, and that TNFSF15 down-regulation is carried out by tumor-infiltrating T-cells under the influence of the cancer cells in the microenvironment. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 468. doi:10.1158/1538-7445.AM2011-468

Inhibition of intracranial hemangioma growth and hemorrhage by TNFSF15.

A Protective Role of Tumor Necrosis Factor Superfamily-15 in Intracerebral Hemorrhage-Induced Secondary Brain Injury

Tnfsf15 Inhibits Vegf-Stimulated Vascular Hyperpermeability by Inducing Vegfr2 Dephosphorylation

TNFSF15 Modulates Neovascularization and Inflammation

Tnfsf15 Inhibits Vasculogenesis by Regulating Relative Levels of Membrane-Bound and Soluble Isoforms of Vegf Receptor 1

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

15, 16-Dihydrotanshinone I Inhibits Hemangiomas Through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo.

Abstract 468: Down-regulation of TNFSF15 (VEGI) in tumor vasculature under inflammatory conditions is a pre-requisite of tumor neovascularization

Restoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brain.

Clinical Significance and Advances Oftnfsf15 Modulation on Tumor Angiogenesis and Lymphangiogenesis

TNFSF15 promotes lymphatic metastasis via up-regulation of VEGFC in a mouse model of lung cancer.

Tumour Necrosis Factor Superfamily Member 15 (tnfsf15) Facilitates Lymphangiogenesis Via Up‐regulation of Vegfr3 Gene Expression in Lymphatic Endothelial Cells

Interferon-γ produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells

Propranolol Inhibits Angiogenesis Via Down-Regulating the Expression of Vascular Endothelial Growth Factor in Hemangioma Derived Stem Cell

Vasculostatin Inhibits Intracranial Glioma Growth and Negatively RegulatesIn Vivoangiogenesis Through a CD36-Dependent Mechanism

Inhibition Of Tumor-Induced Edema By Antisense Vegf Is Mediated By Suppressive Vesiculo-Vacuolar Organelles (Vvo) Formation

Epigenetic Silencing of Mir-130A Ameliorates Hemangioma by Targeting Tissue Factor Pathway Inhibitor 2 Through FAK/PI3K/Rac1/mdm2 Signaling.

Intravenous Somatic Gene Transfer with Antisense Tissue Factor Restores Blood Flow by Reducing Tumor Necrosis Factor-Induced Tissue Factor Expression and Fibrin Deposition in Mouse Meth-a Sarcoma.

[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling

Knockdown of VEGFR2 Inhibits Proliferation and Induces Apoptosis in Hemangioma-Derived Endothelial Cells.

Inhibitory Effect and Mechanism of Human Tumor Necrosis Factor-α Gene Transfected into Human Hepatoma Transplantation Tumor by LipofectamineTM 2000 in Nude Mice